- Butallylonal
- Butallylonal sodium
- 114274-39-45-Benzyloxy-isophthalic acid
- 114275-41-12-AZIDO-1-PIVALOYL-D-ERYTHRO-SPHINGOSINE
- 114275-42-2(2S,3R,4E)-2-AZIDO-3-(TERT-BUTYLDIMETHYLSILYL)-1-PIVALOYL-ERYTHRO-SPHINGOSINE
- 114281-19-5Levitide
- 114289-79-1Phenol,2-(1,1-dimethylethyl)-4-(3-hydroxypropoxy)-6-(5-methoxy-2H-benzotriazol-2-yl)-
- 114290-82-3L-Phenylalanine,N-[2-[[(1,1-dimethylethoxy)carbonyl]amino]-3-phenylpropyl]-, (S)- (9CI)
- 114292-91-02,5-Pyridinediamine, 3-bromo-
- 1142945-83-24-chloro-N-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-2-amine
- 1142946-01-7TG101831
- 1142946-17-54-chloro-N-(4-(4-methylpiperazin-1-yl)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-2-amine
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
| Name |
Butallylonal |
EINECS | N/A |
| CAS No. | 1142-70-7 | Density | 1.395g/cm3 |
| PSA | 75.27000 | LogP | 2.34120 |
| Solubility | 684mg/L(temperature not stated) | Melting Point |
130-133° |
| Formula | C11H15 Br N2 O3 | Boiling Point | °Cat760mmHg |
| Molecular Weight | 303.156 | Flash Point | °C |
| Transport Information | N/A | Appearance | N/A |
| Safety | Poison by ingestion, intravenous, intraperitoneal, and subcutaneous routes. A central nervous system depressant (hypnotic) by ingestion. When heated to decomposition it emits very toxic fumes of Br− and NOx. See also BARBITURATES and ALLYL COMPOUNDS. | Risk Codes | N/A |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
2,4,6(1H,3H,5H)-Pyrimidinetrione,5-(2-bromo-2-propenyl)-5-(1-methylpropyl)- (9CI); Barbituric acid,5-(2-bromoallyl)-5-sec-butyl- (8CI); Butallylonal (6CI);5-(2-Bromoallyl)-5-(1-methylpropyl)barbituric acid;5-(2-Bromoallyl)-5-sec-butylbarbituric acid;5-(2'-Bromallyl)-5-(sec-butyl)barbituric acid; 5-(2'-Bromoallyl)-5-(1'-methyl-n-propyl)barbituricacid; 5-sec-Butyl-5-(b-bromoallyl)barbituric acid; Butylalylonal; Pernocton; Pernoston; Sonbutal |
Butallylonal Chemical Properties
IUPAC Name: 5-(2-bromoprop-2-enyl)-5-butan-2-yl-1,3-diazinane-2,4,6-trione
Synonyms of Butallylonal (CAS NO.1142-70-7): 5-(2'-Bromoallyl)-5-(1'-methyl-n-propyl)barbituric acid ; 5-(2-Bromallyl)-5-sec-butylbarbitursaeure ; 5-(2-Bromo-2-propenyl)-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione ; 5-(2-Bromoallyl)-5-sec-butylbarbituric acid ; 5-24-09-00231 (Beilstein Handbook Reference) ; 5-sec-Butyl-5-(beta-bromoallyl)barbituric acid ; BRN 0249332 ; Butyl-bromallyl-barbitursaeure ; Butylalylonal ; EINECS 214-537-5 ; Pernocton ; Pernoston ; Sonbutal ; 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(2-bromo-2-propenyl)-5-(1-methylpropyl)- (9CI) ; 5-(2-Bromoallyl)-5-(1-methylpropyl)-1H,3H,5H-pyrimidine-2,4,6-trione ; Barbituric acid, 5-(2-bromoallyl)-5-sec-butyl-
CAS NO: 1142-70-7
Molecular Formula of Butallylonal (CAS NO.1142-70-7): C11H15BrN2O3
Molecular Weight: 303.1524
H bond acceptors: 5
H bond donors: 2
Freely Rotating Bonds: 4
Polar Surface Area: 57.69Å2
Index of Refraction: 1.512
Molar Refractivity: 65.19 cm3
Molar Volume: 217.2 cm3
Surface Tension: 39.7 dyne/cm
Density of Butallylonal (CAS NO.1142-70-7): 1.395 g/cm3
Molecular Structure:
.bmp)
Butallylonal Uses
Butallylonal (CAS NO: 1142-70-7) is a barbiturate derivative invented in the 1920s. Butallylonal (CAS NO: 1142-70-7) is considered similar in effects to pentobarbital but is longer in action, being considered an intermediate-acting barbiturate rather than short-acting. Butallylonal (CAS NO: 1142-70-7) was used as an anaesthetic in veterinary medicine.
Butallylonal Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| frog | LDLo | subcutaneous | 150mg/kg (150mg/kg) | Physiological Reviews. Vol. 19, Pg. 472, 1939. | |
| mammal (species unspecified) | LDLo | oral | 350mg/kg (350mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 42, Pg. 253, 1931. | |
| mouse | LDLo | subcutaneous | 150mg/kg (150mg/kg) | J.D. Riedel-E. de Haen A.-G., Laboratory. Vol. #3850, | |
| rabbit | LDLo | intraperitoneal | 75mg/kg (75mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 41, Pg. 465, 1931. | |
| rabbit | LDLo | intravenous | 70mg/kg (70mg/kg) | J.D. Riedel-E. de Haen A.-G., Laboratory. Vol. #3850, | |
| rabbit | LDLo | oral | 350mg/kg (350mg/kg) | J.D. Riedel-E. de Haen A.-G., Laboratory. Vol. #3850, | |
| rabbit | LDLo | subcutaneous | 160mg/kg (160mg/kg) | J.D. Riedel-E. de Haen A.-G., Laboratory. Vol. #3850, | |
| rat | LD50 | subcutaneous | 90mg/kg (90mg/kg) | Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 152, Pg. 341, 1930. | |
| rat | LDLo | intraperitoneal | 65mg/kg (65mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 44, Pg. 325, 1932. |
Butallylonal Safety Profile
Poison by ingestion, intravenous, intraperitoneal, and subcutaneous routes. A central nervous system depressant (hypnotic) by ingestion. When heated to decomposition it emits very toxic fumes of Br− and NOx. See also BARBITURATES and ALLYL COMPOUNDS.
What can I do for you?
Get Best Price
